Clinical trial
Phase 3, Clinical Trials of Drug Against Cutaneous Leishmaniasis
NCT00351520 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3, Clinical Trials of Drug Against Cutaneous Leishmaniasis
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- June 30, 2007
- Enrollment
- 148 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis